Valuation: Sartorius AG

Market Cap 15.67B 17.57B 14.6B 13.29B 25.02B 1,692B 25.21B 176B 68.64B 864B 65.95B 64.53B 2,776B P/E 2026 *
66.4x
P/E 2027 * 50.9x
Enterprise Value 19.25B 21.58B 17.93B 16.32B 30.73B 2,078B 30.96B 217B 84.3B 1,061B 80.99B 79.25B 3,409B EV / Sales 2026 *
5.17x
EV / Sales 2027 * 4.63x
Free-Float
35.87%
Yield 2026 *
0.32%
Yield 2027 * 0.39%
1 day+4.70%
1 week+2.66%
Current month+2.91%
1 month+14.59%
3 months+12.89%
6 months+29.43%
Current year+10.99%
1 week 196.6
Extreme 196.6
212
1 month 181
Extreme 181
214.5
Current year 158.2
Extreme 158.2
214.5
1 year 158.2
Extreme 158.2
214.5
3 years 131.4
Extreme 131.4
290
5 years 131.4
Extreme 131.4
630
10 years 65.02
Extreme 65.02
834
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2025
Director of Finance/CFO 55 01/04/2024
Chief Operating Officer 70 01/01/2001
Director TitleAgeSince
Director/Board Member 62 01/09/2002
Chairman 69 19/07/2017
Director/Board Member 77 29/11/2011
Change 5-day change 1-year change 3-year change Capi.($)
+4.70%+2.66% - - 17.57B
+3.35%-0.27%+24.56%+35.89% 250B
+3.34%-2.69%+2.89%+2.00% 156B
+3.71%-2.00%-10.14%+40.12% 144B
-0.47%-3.88%-56.43%-17.96% 61.45B
+2.44%+0.46%+13.18%+20.82% 50.28B
+1.54%-1.32%-21.07%-19.60% 46.73B
+2.09%-2.24%+20.93%+55.22% 48.29B
+3.70%+1.25%-4.33%+40.74% 45.89B
+3.51%-0.64%+34.02%+65.46% 43.24B
Average +2.34%-2.32%+0.40%+24.74% 93.91B
Weighted average by Cap. +2.54%-2.77%+4.30%+25.38%

Financials

2026 *2027 *
Net sales 3.72B 4.17B 3.47B 3.16B 5.94B 402B 5.99B 41.91B 16.31B 205B 15.67B 15.33B 659B 4.09B 4.58B 3.81B 3.47B 6.53B 441B 6.58B 46.03B 17.91B 225B 17.21B 16.83B 724B
Net income 255M 286M 238M 217M 408M 27.57B 411M 2.87B 1.12B 14.07B 1.07B 1.05B 45.23B 330M 370M 307M 280M 527M 35.61B 531M 3.71B 1.44B 18.18B 1.39B 1.36B 58.42B
Net Debt 3.58B 4.01B 3.33B 3.03B 5.71B 386B 5.75B 40.25B 15.66B 197B 15.04B 14.72B 633B 3.27B 3.67B 3.05B 2.77B 5.22B 353B 5.26B 36.81B 14.32B 180B 13.76B 13.46B 579B
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
14,279
Date Price Change Volume
06/10/26 €212.00 +4.95% 3,306
05/10/26 €202.00 -0.25% 3,589
02/10/26 €202.50 +1.55% 3,608
01/10/26 €199.40 -3.20% 2,690
30/09/26 €206.00 -0.24% 2,777
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
251.60EUR
Average target price
273.63EUR
Spread / Average Target
+8.76%

Quarterly revenue - Rate of surprise